These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 28009325)

  • 1. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
    Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
    Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features].
    Jiang XL; Zhang H; Chen YL; Peng L
    Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755
    [No Abstract]   [Full Text] [Related]  

  • 5. Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
    Lan X; Sun W; Zhang P; He L; Dong W; Wang Z; Liu S; Zhang H
    Tumour Biol; 2016 May; 37(5):6117-23. PubMed ID: 26611646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of serum DKK-1 predicts poor prognosis in patients with papillary thyroid cancer.
    Zhao YP; Wang W; Wang XH; Xu Y; Wang Y; Dong ZF; Zhang JJ
    Genet Mol Res; 2015 Dec; 14(4):18886-94. PubMed ID: 26782539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
    Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
    J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The presence of cancerous nodules in lymph nodes is a novel indicator of distant metastasis and poor survival in patients with papillary thyroid carcinoma.
    Chen L; Zhu Y; Zheng K; Zhang H; Guo H; Zhang L; Wu K; Kong L; Ruan W; Hu J; Zhang X; Chen X
    J Cancer Res Clin Oncol; 2017 Jun; 143(6):1035-1042. PubMed ID: 28204971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
    Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
    APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the HLA-G molecule and lymph node metastasis in papillary thyroid cancer.
    Nunes LM; Ayres FM; Francescantonio IC; Saddi VA; Avelino MA; Alencar Rde C; Silva RC; Meneghini AJ; Wastowski IJ
    Hum Immunol; 2013 Apr; 74(4):447-51. PubMed ID: 23261411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymosin beta 10 correlates with lymph node metastases of papillary thyroid carcinoma.
    Zhang XJ; Su YR; Liu D; Xu DB; Zeng MS; Chen WK
    J Surg Res; 2014 Dec; 192(2):487-93. PubMed ID: 24974154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
    Jia M; Guo Y; Lu X
    Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Wang W; Su X; He K; Wang Y; Wang H; Wang H; Zhao Y; Zhao W; Zarnegar R; Fahey TJ; Teng X; Teng L
    Cancer; 2016 Jan; 122(2):198-206. PubMed ID: 26506214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
    Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
    PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma.
    Kim HJ; Park HK; Byun DW; Suh K; Yoo MH; Min YK; Kim SW; Chung JH
    Head Neck; 2015 May; 37(5):650-4. PubMed ID: 24590814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
    Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
    Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HIF-2α, TWIST, and CXCR4 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Luo HJ; Yin GB; Dong CR; Xu M; Chen GG; Liu ZM
    Clin Dev Immunol; 2013; 2013():589423. PubMed ID: 24288553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and clinical significance of STIP1 in papillary thyroid carcinoma.
    Yuan MH; Zhou RS; She B; Xu HF; Wang JY; Wei LX
    Tumour Biol; 2014 Mar; 35(3):2391-5. PubMed ID: 24163084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.